Literature DB >> 32071491

Progeria: A Rare Genetic Syndrome.

Veena Sharma1, Richa Shukla1.   

Abstract

An uncommon deadly genetic situation symbolized by the presence of rapid maturation in infants is called as the Hutchinson-Gilford Progeria Syndrome. The term basically is meant as 'prematurely old' taken from the Greek meanings. The selective cause behind this syndrome is usually a mutation in a gene called LMNA. The product of this LMNA gene which is a protein i.e. Lamin-A is considered to be responsible for anatomical framing which clasps the nuclei of the cell, well organized and together. But, the recent investigations prove a deformity in the protein i.e. Lamin-A that leads to the non-stability of the nuclei an thus gives rise to the deadly situation of untimely ageing in the children popularly known as Progeria. The literature review investigation provided pivotal information about the therapeutic researches related to the syndrome, the mutational causes and the basic information including the major and minor symptoms generally shown by the patients affected with Hutchinson-Gilford Progeria Syndrome. Investigations on this rare, uncommon disease i.e. Progeria had begun a couple of years back and in some of the researches many important aspects about the causes and possible curative drugs related to the disease which can help the patients in leading a normal life with lesser side effects and symptoms have also been discussed. Further studies will more clearly clarify the possible curative agents and unrevealed mechanisms of the disease which will help the scientists to develop measures which can provide more beneficial and healthy life to the patients with lesser complications. © Association of Clinical Biochemists of India 2019.

Entities:  

Keywords:  Hutchinson–Gilford Progeria Syndrome; Prelamin-A; Progerin

Year:  2019        PMID: 32071491      PMCID: PMC6995454          DOI: 10.1007/s12291-019-00849-6

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  24 in total

Review 1.  Farnesyltransferase inhibitors.

Authors:  Alex A Adjei
Journal:  Cancer Chemother Biol Response Modif       Date:  2005

2.  The defective nuclear lamina in Hutchinson-gilford progeria syndrome disrupts the nucleocytoplasmic Ran gradient and inhibits nuclear localization of Ubc9.

Authors:  Joshua B Kelley; Sutirtha Datta; Chelsi J Snow; Mandovi Chatterjee; Li Ni; Adam Spencer; Chun-Song Yang; Caelin Cubeñas-Potts; Michael J Matunis; Bryce M Paschal
Journal:  Mol Cell Biol       Date:  2011-06-13       Impact factor: 4.272

3.  Lamin A precursor induces barrier-to-autointegration factor nuclear localization.

Authors:  Cristina Capanni; Vittoria Cenni; Tokuko Haraguchi; Stefano Squarzoni; Stefan Schüchner; Egon Ogris; Giuseppe Novelli; Nadir Maraldi; Giovanna Lattanzi
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

4.  Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome.

Authors:  Maria Eriksson; W Ted Brown; Leslie B Gordon; Michael W Glynn; Joel Singer; Laura Scott; Michael R Erdos; Christiane M Robbins; Tracy Y Moses; Peter Berglund; Amalia Dutra; Evgenia Pak; Sandra Durkin; Antonei B Csoka; Michael Boehnke; Thomas W Glover; Francis S Collins
Journal:  Nature       Date:  2003-04-25       Impact factor: 49.962

Review 5.  HGPS and related premature aging disorders: from genomic identification to the first therapeutic approaches.

Authors:  Sandrine Pereira; Patrice Bourgeois; Claire Navarro; Vera Esteves-Vieira; Pierre Cau; Annachiara De Sandre-Giovannoli; Nicolas Lévy
Journal:  Mech Ageing Dev       Date:  2008-04-12       Impact factor: 5.432

6.  An association of Hutchinson-Gilford progeria and malignancy.

Authors:  Stavit A Shalev; Annachiara De Sandre-Giovannoli; Ayelet Adir Shani; Nicolas Levy
Journal:  Am J Med Genet A       Date:  2007-08-15       Impact factor: 2.802

7.  Farnesyltransferase inhibitor treatment restores chromosome territory positions and active chromosome dynamics in Hutchinson-Gilford progeria syndrome cells.

Authors:  Ishita S Mehta; Christopher H Eskiw; Halime D Arican; Ian R Kill; Joanna M Bridger
Journal:  Genome Biol       Date:  2011-08-12       Impact factor: 13.583

8.  Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation.

Authors:  S Blondel; A-L Egesipe; P Picardi; A-L Jaskowiak; M Notarnicola; J Ragot; J Tournois; A Le Corf; B Brinon; P Poydenot; P Georges; C Navarro; P R Pitrez; L Ferreira; G Bollot; C Bauvais; D Laustriat; A Mejat; A De Sandre-Giovannoli; N Levy; M Bifulco; M Peschanski; X Nissan
Journal:  Cell Death Dis       Date:  2016-02-18       Impact factor: 8.469

9.  Rapamycin fed late in life extends lifespan in genetically heterogeneous mice.

Authors:  David E Harrison; Randy Strong; Zelton Dave Sharp; James F Nelson; Clinton M Astle; Kevin Flurkey; Nancy L Nadon; J Erby Wilkinson; Krystyna Frenkel; Christy S Carter; Marco Pahor; Martin A Javors; Elizabeth Fernandez; Richard A Miller
Journal:  Nature       Date:  2009-07-08       Impact factor: 49.962

10.  Prelamin A causes progeria through cell-extrinsic mechanisms and prevents cancer invasion.

Authors:  Jorge de la Rosa; José M P Freije; Rubén Cabanillas; Fernando G Osorio; Mario F Fraga; M Soledad Fernández-García; Roland Rad; Víctor Fanjul; Alejandro P Ugalde; Qi Liang; Haydn M Prosser; Allan Bradley; Juan Cadiñanos; Carlos López-Otín
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.